Cristal Therapeutics is a clinical stage biopharma company developing the next generation nanomedicines based on its proprietary CriPec platform to treat various diseases, including cancer.
Cristal Therapeutics is a clinical stage biopharma company developing the next generation nanomedicines based on its proprietary CriPec platform to treat various diseases, including cancer.
PX Biosolutions is a biotech company developing a novel vaccine adjuvant platform technology, DCtag, with prophylactic and therapeutic utility in both human and animal applications.
Wyatt Technology is a biotech company providing some of the most advanced tools for absolute macromolecular characterization.
DLVR Therapeutics is developing an innovative, HDL-like Peptide-Phospholipid Scaffold (HPPS) nanoparticle delivery system, initially for RNAi therapeutics.